Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Helius Medical Technologies Inc HSDT

Healthcare Medical Devices
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing... see more

Recent & Breaking News (NDAQ:HSDT)

Helius Medical Technologies to Release Second Quarter of Fiscal Year 2020 Financial Results on August 12, 2020

GlobeNewswire August 10, 2020

Helius Medical Technologies, Inc. Submits Request for FDA Clearance for PoNS(TM) Device; Reports Preliminary Financial Results for the Second Quarter and Six Months Ended June 30, 2020

GlobeNewswire August 6, 2020

Helius Medical Technologies Announces the Dismissal of the Shareholder Class Action Lawsuit

GlobeNewswire July 14, 2020

Helius Medical Technologies to Present at the Virtual Summer Summit on June 9th

GlobeNewswire June 5, 2020

Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis

GlobeNewswire May 12, 2020

Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook

GlobeNewswire May 7, 2020

UPDATE -- Helius Medical Technologies, Inc. Announces Publication of its PoNS(TM) Registrational Clinical Trial (TBI-001) in TBI

GlobeNewswire April 30, 2020

Helius Medical Technologies, Inc. Announces Publication of its PoNS(TM) Registrational Clinical Trial (TBI-001) in TBI

GlobeNewswire April 30, 2020

Helius Medical Technologies to Release First Quarter of Fiscal Year 2020 Financial Results on May 7, 2020

GlobeNewswire April 22, 2020

Helius Medical Technologies Appoints Jeffrey S. Mathiesen to its Board of Directors

GlobeNewswire April 22, 2020

Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS(TM) Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS)

GlobeNewswire March 24, 2020

Helius Medical Technologies Announces $2.2 Million Registered Direct Offering

GlobeNewswire March 18, 2020

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results; Introduces Full Year 2020 Outlook

GlobeNewswire March 12, 2020

Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment(TM) Clinics

GlobeNewswire March 9, 2020

Helius Medical Technologies Reports Preliminary Unaudited Fourth Quarter and Full Year Unaudited 2019 Financial Results, Provides Commercial and Regulatory Update and Announces Submission to Health Canada for Multiple Sclerosis (MS) Label Expansion and New US Regulatory Prioritization for MS

GlobeNewswire March 2, 2020

Helius Medical Technologies CEO Philippe Deschamps to Deliver Congressional Briefing on the Latest Technologies, Innovations and Policies in Clinical Neuroscience

GlobeNewswire February 24, 2020

Helius Medical Technologies Inc. Welcomes Cline Medical Centre as an Authorized PoNS Treatment(TM) Clinic in Nanaimo, BC

GlobeNewswire February 7, 2020

Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 12, 2020

GlobeNewswire February 5, 2020

Helius Medical Technologies, Inc. Issues a Clarification to the News Release Regarding the Agreement with the University Health Network (UHN) Issued at 7:05 am January 16, 2020

GlobeNewswire January 16, 2020

Helius Medical Technologies, Inc. and University Health Network (UHN) Have Signed an Agreement for UHN and three Neuro-Rehabilitation Centers to Perform a Clinical Experience Program of the PoNS(TM) Device in Canada

GlobeNewswire January 16, 2020